Stephen Hoge

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ James Dillon, as Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Stephen Hoge

Form 4 holding President

Moderna, Inc.

Security class
Restricted Stock Units
Shares / value
102,111
Estimated value
$4,617,611
Report date
01 Jun 2026
Price
$31.09
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Axcella Health Inc.

Security class
Stock Option (Right to Buy)
Shares / value
20,000
Estimated value
Report date
20 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President

Moderna, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
16,110
Estimated value
Report date
15 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Stephen Hoge

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .